Aurobindo, Hetero, and Vivimed Class Action Settlements in Massachusetts
Aurobindo, Hetero, and Vivimed class action settlements that covered Massachusetts residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Massachusetts residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Massachusetts Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Massachusetts
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Massachusetts residents affected by Aurobindo, Hetero, and Vivimed pharmaceutical settlements benefit from the state's Consumer Protection Act (Chapter 93A), which provides additional remedies beyond federal class action recoveries. This law allows consumers to seek double or triple damages for unfair business practices, potentially supplementing settlement amounts. These three generic drug manufacturers have significant distribution networks throughout Massachusetts, with Aurobindo maintaining regulatory submissions through Boston-area consultants and all three companies supplying major pharmacy chains like CVS Health, which is headquartered in Rhode Island but operates extensively in Massachusetts. The $15.2 million Valsartan, Losartan and Irbesartan settlement involves these manufacturers and affects thousands of Massachusetts patients who received contaminated blood pressure medications. Massachusetts residents filing class action claims must be aware that the state's three-year statute of limitations under Chapter 93A runs separately from federal class action deadlines. Claims can be filed in Massachusetts state courts even when federal settlements are pending, though coordination between proceedings typically occurs to avoid double recovery.
Aurobindo, Hetero, and Vivimed Settlements in Massachusetts: FAQs
How does Massachusetts' Consumer Protection Act affect my Aurobindo, Hetero, and Vivimed settlement claim?
Massachusetts General Laws Chapter 93A provides additional protection beyond federal class action settlements, allowing you to potentially recover attorney fees and damages up to three times your actual losses. However, you cannot recover under both Chapter 93A and federal settlements for the same harm, so coordination with existing class actions like the $15.2M blood pressure medication settlement is essential.
Can Massachusetts residents file separate state claims against Aurobindo, Hetero, and Vivimed while federal settlements are pending?
Yes, Massachusetts residents can file state court actions under Chapter 93A even during federal proceedings. The Massachusetts statute of limitations runs independently from federal class action deadlines, giving residents additional time to pursue claims if they discover harm after federal deadlines pass.
Are Massachusetts residents automatically included in the Aurobindo, Hetero, and Vivimed Valsartan settlement?
Massachusetts residents who purchased or were prescribed the contaminated Valsartan, Losartan, or Irbesartan medications from these manufacturers between specified dates are typically included in the settlement class. You should verify your medication manufacturer through prescription records and may need to submit a claim form to receive compensation from the $15.2 million settlement fund.
Tips for Massachusetts Residents Filing Aurobindo, Hetero, and Vivimed Claims
Massachusetts residents filing Aurobindo, Hetero, and Vivimed claims should preserve all prescription records, pharmacy receipts, and medical documentation showing use of affected medications. Contact your pharmacy to identify the specific manufacturer of your blood pressure medications, as multiple companies produced these drugs. File claims promptly even if you haven't experienced health problems, as the $15.2 million settlement may provide compensation for monitoring costs. Consider consulting a Massachusetts attorney familiar with Chapter 93A if you suffered serious health complications, as state law remedies might exceed federal settlement amounts. Monitor settlement administration websites regularly for updates on claim forms and deadlines.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
